Abstract
Human platelets are released from the cytoplasm of megakaryocytes and average 2-3 μm in diameter. In response to vascular injury, platelets stick together like glue, seal the wounded area, and dispense their contents into the nearby milieu. Taken at face value, these features and functions seem simplistic and unrefined. As one digs deeper, however, it becomes apparent that platelets are intricately wired and created for multifunctional purposes. One of their duties, which cropped up over the last decade, is to synthesize proteins both continually and on demand. It turns out that platelets possess thousands of template mRNAs, ribosomes, and requisite translational machinery that they use to generate new proteins. Platelets also retain tools that grant them the ability to process precursor mRNAs and microRNAs. In this review, we briefly describe what we currently know about protein synthesis in platelets, its functional significance, and where the field is likely to take us over the next decade.
Keywords: mRNA, platelets, protein synthesis, ribosomes, splicing, translation, synthetic pathways, megakaryocytes, thrombopoiesis, mechanisms, Leukocytes, glycoprotein
Current Proteomics
Title: Platelet Protein Synthesis and Translational Control
Volume: 8 Issue: 3
Author(s): Robert A. Campbell, Neal D. Tolley, Hansjorg Schwertz and Andrew S. Weyrich
Affiliation:
Keywords: mRNA, platelets, protein synthesis, ribosomes, splicing, translation, synthetic pathways, megakaryocytes, thrombopoiesis, mechanisms, Leukocytes, glycoprotein
Abstract: Human platelets are released from the cytoplasm of megakaryocytes and average 2-3 μm in diameter. In response to vascular injury, platelets stick together like glue, seal the wounded area, and dispense their contents into the nearby milieu. Taken at face value, these features and functions seem simplistic and unrefined. As one digs deeper, however, it becomes apparent that platelets are intricately wired and created for multifunctional purposes. One of their duties, which cropped up over the last decade, is to synthesize proteins both continually and on demand. It turns out that platelets possess thousands of template mRNAs, ribosomes, and requisite translational machinery that they use to generate new proteins. Platelets also retain tools that grant them the ability to process precursor mRNAs and microRNAs. In this review, we briefly describe what we currently know about protein synthesis in platelets, its functional significance, and where the field is likely to take us over the next decade.
Export Options
About this article
Cite this article as:
A. Campbell Robert, D. Tolley Neal, Schwertz Hansjorg and S. Weyrich Andrew, Platelet Protein Synthesis and Translational Control, Current Proteomics 2011; 8 (3) . https://dx.doi.org/10.2174/157016411797247521
DOI https://dx.doi.org/10.2174/157016411797247521 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies for Efficient Lead Structure Discovery from Natural Products
Current Medicinal Chemistry Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma
Current Pharmaceutical Biotechnology HDAC Inhibitors-New Generation of Target Specific Treatment
Mini-Reviews in Medicinal Chemistry Cadherins: The Superfamily Critically Involved in Breast Cancer
Current Pharmaceutical Design Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease
Current Medicinal Chemistry Discovery of Novel Cell Proliferation-Enhancing Gene by Random siRNA Library Based Combinatorial Screening
Combinatorial Chemistry & High Throughput Screening Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Nanoscience & Nanotechnology-Asia Destabilizing Aneuploidy by Targeting Cell Cycle and Mitotic Checkpoint Proteins in Cancer Cells
Current Drug Targets An In Silico Immunogenicity Analysis for PbHRH: An Antiangiogenic Peptibody by Fusing HRH Peptide and Human IgG1 Fc Fragment
Current Bioinformatics Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Current Drug Targets Peptido-Targeting of the Mitochondrial Transition Pore Complex for Therapeutic Apoptosis Induction
Current Pharmaceutical Design Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry Characterization of the Early CNS Stress Biomarkers and Profiles Associated with Neuropsychiatric Diseases
Current Genomics Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Pharmacogenomics: The Influence of Genomic Variation on Drug Response
Current Topics in Medicinal Chemistry Enhancing the Therapeutic Efficacy of Bortezomib in Cancer Therapy Using Polymeric Nanostructures
Current Pharmaceutical Design Benzimidazoles: An Ideal Privileged Drug Scaffold for the Design of Multitargeted Anti-inflammatory Ligands
Mini-Reviews in Medicinal Chemistry Toxicity and Surface Modification of Dendrimers: A Critical Review
Current Drug Delivery STAT3 as a Therapeutic Target for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: Oncohematology: From Bench to Bedside (Guest Editor: Vincenzo De Feo)]
Mini-Reviews in Medicinal Chemistry